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Abstract
Coronary artery disease is the leading cause of death in advanced countries. Early detection and diagnosis of 
coronary artery disease plays an important role in the identification of disease severity and prediction of disease 
outcome, consequently improving patient management. Diagnosis and management of coronary artery disease is 
increasingly dependent on less-invasive imaging modalities, including coronary CT angiography, cardiac magnetic 
resonance imaging, cardiac radionuclide imaging such as SPECT and PET modalities. Rapid developments of 
these imaging modalities have significantly improved the diagnostic performance of each imaging technique with 
high diagnostic accuracy achieved in both diagnostic and prognostic value in coronary artery disease. This editorial 
provides an overview of the diagnostic applications of a variety of less-invasive imaging modalities in the diagnosis of 
coronary artery disease. This special issue of “Arteriosclerotic Vascular Disease: Part II” in the journal of Clinical and 
Experimental Cardiology will give particular attention to contributions focusing on the clinical applications of these 
imaging modalities in the arteriosclerotic vascular disease, in particular, coronary artery disease.
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Coronary artery disease (CAD) is the leading cause of death 
in advanced countries and its prevalence is increasing among 
developing countries [1,2]. Various less-invasive imaging modalities 
are increasingly used in the diagnosis of CAD including coronary 
CT angiography, cardiac magnetic resonance imaging (MRI), and 
cardiac single photon emission computed tomography (SPECT), 
positron emission tomography (PET) and integrated SPECT/CT and 
PET/CT [3]. To improve early diagnosis and patient management, 
it is essential to have an overview of the diagnostic value of different 
imaging modalities in CAD. This editorial provides an overview of the 
diagnostic performance of these imaging modalities in CAD, with a 
focus on the advantages, limitations and future directions of the use of 
each imaging modality in the diagnosis of CAD.
Coronary CT angiography represents the most rapidly developed 
imaging modality in cardiac imaging with evolution from single slice 
CT to multislice CT, from early generation of 4- and 16-slice CT to 
64- and 320-slice CT scanners, demonstrating excellent visualization 
of coronary anatomy and assessment of coronary artery disease [4-
6]. In summary, diagnostic sensitivity of coronary CT angiography 
has been significantly improved with 64- or more slice CT scanners 
when compared to the early generations of 4- and 16-slice scanners, 
while, the negative predictive value remains consistently high (>90%), 
regardless of the type of CT scanners [7-11]. This indicates the main 
role of coronary CT angiography is to rule out significant CAD, thus 
reducing the need for invasive coronary angiography. The prime 
indication of coronary CT angiography is to diagnose patients with 
a low and intermediate probability of CAD as a simple non-invasive 
testing, while patients with a high probability of CAD will benefit from 
invasive coronary angiography [12].
In addition to the diagnostic value, coronary CT angiography 
allows for characterization of plaque components (calcified versus 
non-calcified plaques and shows potential prognostic value of disease 
extent and cardiac events [13,14]. Studies based on single center and 
multicenter clinical trials have shown that coronary CT angiography 
provides incremental prognostic value over clinical risk analysis in 
predicting major adverse cardiac events with absence of CAD leading 
to event free survival period, while presence of plaques associated with 
increased risk of cardiac events [15-19].
Radiation dose associated with coronary CT angiography is 
the main concern of this technique in cardiac imaging, and this has 
increased substantially over the last decade with the development of 
multislice CT scanners and widespread use of cardiac CT in routine 
clinical practice. This has raised a serious concern and it is a hot topic 
of debate in the literature. Various dose-saving strategies have been 
proposed and recommended in the past few years to lower radiation 
exposure to patients undergoing coronary CT angiography with 
tremendous progress having been achieved. Effective dose reduction 
has been accomplished by employing techniques with a radiation 
dose of less than 10 mSv to as low as 1 mSv in some studies [11,20,21], 
although much effort is still required to ensure that coronary CT 
angiography is safely performed in imaging patients with suspected 
coronary artery disease.
MRI provides excellent soft tissue contrast, with inherent 3D 
capabilities, and acquisition of images in any anatomical plane. 
Furthermore, MRI does not expose the patient to ionizing radiation, 
thus, the usefulness of MRI has been investigated widely. However, the 
diagnostic accuracy of cardiac MRI in CAD varies widely according to 
the literature, with sensitivity ranging from 38% to 83%, and specificity 
ranging from 57% to 95% due to variable scanning protocols used in 
the studies [22]. Recent technical developments in MRI, especially with 
the emergence of 3.0 T MR imaging system have been shown to be 
a promising technique for performing cardiac MRI, with significant 
improvement of diagnostic value for detection of CAD [23,24]. Despite 
these advantages, cardiac MRI is still limited in the visualization of 
distal coronary segments due to inferior spatial resolution, thus, it is 
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not as widely used as coronary CT angiography in the diagnosis of 
CAD.
Noninvasive evaluation for obstructive CAD is performed by 
gatekeeper tests that offer physiologic information of coronary stenosis 
(physiologic imaging) or the degree of stenosis (anatomic imaging). 
Coronary CT angiography serves as an excellent anatomic gatekeeper 
as it has a very high negative predictive value, while stress perfusion 
cardiac MRI is a regarded as a physiologic gatekeeper. Stress perfusion 
cardiac MRI has been proved to be a robust and accurate diagnostic test 
for CAD when invasive coronary angiography is used as the reference 
standard [25-28]. Several systematic reviews and meta-analyses have 
shown that the sensitivity and specificity of stress perfusion MRI 
ranged from 89% to 91% and 76% to 81%, using invasive coronary 
angiography as the reference standard [26-28]. Desai and Jha recently 
conducted a meta-analysis of 12 studies regarding the cardiac stress 
perfusion MRI in the diagnosis of flow-limiting obstructive CAD using 
fractional flow reserve measured at invasive coronary angiography as 
the reference standard [29]. Their analysis shows that cardiac stress 
perfusion MRI has a sensitivity of 89.1% and 87.7% and a specificity of 
84.9% and 88.6% on a patient-based and on a coronary territory-based 
analysis, respectively. Thus, cardiac stress perfusion MRI is an accurate 
test for the detection of low-limiting stenosis.
Myocardial perfusion imaging (MPI) with stress gated SPECT has 
been widely used in the diagnosis of CAD and is a well-documented 
non-invasive method for risk stratification with high diagnostic 
accuracy when compared to coronary CT angiography [30,31]. The 
presence of ischemia could be used to classify the patients as having 
CAD and candidates for receiving aggressive medical therapy and 
management. Coronary CT angiography has limited accuracy for 
identifying the physiologic significance of perfusion defects in patients 
with intermediate or high pre-test likelihood of CAD when compared 
to MPI SPECT [32]. Thus, MPI SPECT offers additional function 
information in the evaluation of coronary stenosis.MPI SPECT can 
be used as the gatekeeper to invasive coronary angiography. Bateman 
et al. showed that referral to invasive coronary angiography was 
3.5%, 9%, and 60%, respectively, corresponding to normal to mild, 
moderately abnormal and severely abnormal perfusion scans [33]. A 
negative SPECT imaging has been confirmed to serve as an excellent 
prognostic indicator with an annual cardiac event rate of <1% for the 
general population, while an increasing cardiac events are associated 
with increasing severity of both fixed and reversible perfusion defects, 
regardless of the presence of non-obstructive coronary disease [34-36].
Cardiac PET imaging is another well-established tool for the 
evaluation of ischemia, blood flow quantification, myocardial viability 
and perfusion [37,38]. Cardiac PET utilizing 18F-FDG is considered the 
most sensitive modality for detecting hibernating viable myocardium 
and predicting left ventricular functional recovery post-coronary 
revascularization. PET has higher spatial and temporal resolution 
than SPECT due to more robust methods of attenuation correction, 
thus, PET allows quantification of resting and hyperemic regional 
myocardial perfusion. When PET was integrated into clinical patient 
management, a significant reduction in cardiac events was observed 
in patients with 18F-FDG PET-assisted management, according to 
randomized controlled trials [39,40]. PET images provide incremental 
prognostic information to the clinical and angiographic findings with 
regard to event-free survival. An increased extent and severity of 
perfusion defects with stress PET were reported to be associated with 
increased frequency of adverse cardiac events, thus, this indicates PET 
can be used to predict cardiac mortality [41,42].
Cardiac PET is not yet as widely available as SPECT imaging. 
Furthermore, experience in image interpretation and operation 
may vary widely. Cardiac PET will continue to play a key role in the 
investigation of myocardial viability and perfusion contributing more 
to available data.
Integrated SPECT/PET-multislice CT has huge potential for 
cardiac imaging. The incremental value of hybrid imaging lies in 
accurate spatial co-localization of myocardial perfusion defects and 
anatomic coronary arteries. This combined technology allows detection 
and quantification of the burden of calcified and non-calcified plaques, 
quantification of vascular activity and endothelial health, identification 
of flow-limiting coronary stenosis, and potentially identification 
of high-risk plaques in the coronary artery tree [43]. Combined 
SPECT/CT and PET/CT systems are today well established in clinical 
routine imagingwith promising results reports [44-48], although 
more multicentre trials are needed to validate the diagnostic value 
of the hybrid imaging modalities. Combined PET/MRI represents 
another new integrated protocol, however, it is only limited to a few 
clinical centers for preclinical cardiac imaging with a focus on animal 
experiments [49,50].
In summary, this editorial briefly reviews the diagnostic 
applications of these less-invasive imaging modalities including 
coronary CT angiography, cardiac MRI, cardiac SPECT and cardiac 
PET in coronary artery disease. Advantages and limitations of each 
imaging modality in the detection of coronary artery disease are also 
highlighted. Researchers are encouraged to contribute both original 
and review papers to this special issue with the aim of delivering both 
educational and teaching message to clinicians with research interests 
in cardiac imaging.
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